Join
Live feed
·
PRReleasevia Quantisnow
Geron Corporation logo

Geron Corporation Announces Five Presentations Selected for ASH 2025 Highlighting Clinical Activity of RYTELO® (imetelstat) in Myeloid Hematologic Malignancies

ByQuantisnow·Wall Street's wire, on your screen.
GERN· Geron Corporation
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GERN (Geron Corporation) and more on Quantisnow.